Linical Co (TSE:2183) Beginning Cash Position: 円5,400 Mil (As of Mar. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Linical Co Ltd TSE:2183

44 GF Score

Price 円206.00

GF Value 円324.16

Valuation Possible Value Trap

5 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Linical Co Beginning Cash Position?

Linical Co TSE:2183 +0.49% 44 Beginning Cash Position is 円5,400 Mil as of Mar. 2026. GuruFocus rates TSE:2183 with a GF Score™ of 44/100 and a GF Value™ of 円324.16 (Possible Value Trap). The stock has 5 warning signs investors should review.

Linical Co's Beginning Cash Position for the quarter that ended in Mar. 2026 was 円5,400 Mil.

Linical Co's quarterly Beginning Cash Position declined from Mar. 2025 (円7,214 Mil) to Sep. 2025 (円7,040 Mil) and declined from Sep. 2025 (円7,040 Mil) to Mar. 2026 (円5,400 Mil).

Linical Co's annual Beginning Cash Position increased from Mar. 2024 (円7,042 Mil) to Mar. 2025 (円7,465 Mil) but then declined from Mar. 2025 (円7,465 Mil) to Mar. 2026 (円7,040 Mil).

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Linical Co Beginning Cash Position Related Terms

Linical Co Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Linical Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Linical Co Beginning Cash Position Chart

Linical Co Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

Beginning Cash Position

Get a 7-Day Free Trial

5,084.20

5,985.62

7,042.10

7,465.19

7,039.57

Linical Co Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25	Sep25	Mar26
Beginning Cash Position	Get a 7-Day Free Trial															-0.00	7,465.19	7,213.71	7,039.57	5,400.49

44GF Score

Linical Co Ltd TSE:2183

Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Linical Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Frequently Asked Questions Learn more about Beginning Cash Position →

What does a Beginning Cash Position of 円5,400 Mil mean?

Linical Co (TSE:2183) has a Beginning Cash Position of 円5,400 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Linical Co and its competitors.

Is Linical Co's Beginning Cash Position too high?

Linical Co's current Beginning Cash Position is 円5,400 Mil. Overall, Linical Co has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Linical Co's Beginning Cash Position compare to VRTX and REGN?

Linical Co's Beginning Cash Position of 円5,400 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Beginning Cash Position for a Biotechnology company?

A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Beginning Cash Position mean?

A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Linical Co and its competitors. Linical Co's current Beginning Cash Position is 円5,400 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Linical Co stock overvalued right now?

Based on GuruFocus' analysis, Linical Co (TSE:2183) is currently considered Possible Value Trap. The stock's GF Value™ is 円324.16, compared to a current price of 円206.00 — trading 36.5% below its estimated fair value. The current Beginning Cash Position is 円5,400 Mil. Linical Co's overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Beginning Cash Position calculated?

Beginning Cash Position is calculated from a company's financial statements. For Linical Co (TSE:2183), the current Beginning Cash Position is 円5,400 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Linical Co (TSE:2183) Overvalued in 2026?

Based on GuruFocus' analysis, Linical Co stock appears to be undervalued. The current stock price of 円206.00 is trading 36.5% below its estimated GF Value™ of 円324.16. GuruFocus considers Linical Co to be Possible Value Trap.

Key valuation signals for TSE:2183:

Beginning Cash Position: 円5,400 Mil
GF Value™: 円324.16 vs. price of 円206.00 (36.5% below fair value)
GF Score™: 44/100 with 5 warning signs

No single metric tells the full story. See the TSE:2183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →